Sign in
8-K

Current Report

Vistagen Therapeutics, Inc. Filed Acc 0001437749-23-016689

Shareholder rights changed · Bylaws or fiscal year change · Regulation FD disclosure

  • Item 3.03 Material modification to rights of security holders
  • Item 5.03 Amendments to articles or bylaws; change in fiscal year
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading vtgn20230605_8k.htm…